Home › Mining › Nova Minerals (ASX:NVA)

Nova Minerals warns funding may not cover planned operations for 12 months

Mining By Maxwell Dee 4 min read

Nova Minerals has cleared the final regulatory hurdle for its Alaska antimony pilot project, but the milestone arrives alongside a US$12.0 million quarterly loss and a warning that existing resources may not fund planned operations for 12 months. The company is targeting 2027 pilot-scale production while relying on further government reimbursements and new capital.

  • Final Alaska approvals secured for the three-year antimony pilot project
  • US$12.0 million quarterly net loss, up from US$6.4 million
  • Cash fell to US$17.8 million after US$8.99 million quarterly decline
  • US$19.6 million remains under the Department of War award
  • Management disclosed substantial doubt over continued operations

Antimony permits clear the path to 2027 pilot production

Nova Minerals Corp (ASX:NVA; NYSE American:NVA) has secured the final approvals for its integrated Alaska antimony development, removing a major regulatory obstacle while leaving a more immediate financial one in plain view. The approvals, received from the Alaska Department of Natural Resources on 27 October, cover ore extraction at the Styx and Stibium prospects, sorting and processing at Whiskey Bravo, and downstream refining at Port MacKenzie.

The permit milestone follows the delivery of approximately 500 tons of processing and refining equipment to Port MacKenzie, with early earthworks and site preparation already underway. That equipment delivery was covered in the company’s 500 tons of antimony equipment earlier announcement. Nova says the project remains targeted at pilot-scale production in 2027, with the stated objective of producing military-grade antimony trisulfide under its US$43.4 million Department of War award.

Quarterly spending widens loss and drains cash

The financial numbers are less forgiving. Nova reported a US$12.05 million net loss for the three months ended 30 September, compared with US$6.43 million a year earlier. Exploration and evaluation spending rose to US$11.68 million from US$6.28 million, reflecting the larger field programme, drilling, mining studies, freight and antimony development work.

Cash and cash equivalents fell from US$26.78 million at 30 June to US$17.76 million at quarter-end. Nova used US$4.94 million in operating activities and another US$3.84 million on plant and equipment, while the quarter included collection of a US$5.5 million government-grant receivable. The company completed about 8,000 metres of gold and antimony drilling, collected roughly 100 tons of antimony-bearing material for pilot-scale feedstock and continued gold flotation test work to support its gold pre-feasibility study.

Going concern warning puts funding ahead of construction

Management concluded that substantial doubt exists about Nova’s ability to continue as a going concern for one year from the date the financial statements were issued. The company said its current resources are not sufficient to fund planned operations over that period and expects to rely on existing cash, further Department of War claims, additional debt or equity financing, and adjustments to discretionary spending.

Approximately US$23.9 million of the award had been received by 30 September, leaving US$19.6 million subject to milestones and reimbursement processes. Following the permit approval, Nova invoiced a further US$5.0 million and expects payment before 31 December 2026, according to the filing. The remaining funding is expected during fiscal 2027, but the company also acknowledges that government payments are conditional and that new financing may not be available on acceptable terms.

Internal control weakness remains unresolved

The 10-Q also says disclosure controls were not effective at 30 September because of an unremediated material weakness in financial reporting controls. The weakness relates to staffing and technical accounting capability, inconsistent processes and the design and operation of the financial close process. Management said remediation work is continuing, but the weakness will not be considered resolved until the controls operate effectively for a sufficient testing period.

That leaves Nova with a project that is more permitted and better equipped than it was a quarter ago, but still dependent on execution, milestone payments and external capital. The next meaningful evidence will be whether the US$5.0 million invoice is paid as expected and whether the company can convert its expanding equipment base and bulk samples into a functioning pilot operation without accelerating the need for shareholder funding.

Bottom Line?

Permitting has improved the project’s execution position, but Nova’s 2027 ambition now depends on timely award receipts and additional funding before cash runs too low.

Questions in the middle?

  • Will the invoiced US$5.0 million Department of War milestone be received before year-end?
  • How much additional equity or debt capital will Nova need before pilot-scale production begins?
  • Can the company remediate its material weakness while managing construction, commissioning and exploration demands?

Sources